• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Reshaping Tumor Size through Insights from Pancreatic Cancer Imaging and Pathology.

作者信息

Kobayashi Kazuki, Kishi Yoji

机构信息

Department of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.

出版信息

Ann Surg Oncol. 2025 May;32(5):3625. doi: 10.1245/s10434-025-16983-w. Epub 2025 Feb 15.

DOI:10.1245/s10434-025-16983-w
PMID:39955451
Abstract
摘要

相似文献

1
ASO Author Reflections: Reshaping Tumor Size through Insights from Pancreatic Cancer Imaging and Pathology.ASO作者反思：通过胰腺癌成像与病理学见解重塑肿瘤大小
Ann Surg Oncol. 2025 May;32(5):3625. doi: 10.1245/s10434-025-16983-w. Epub 2025 Feb 15.
2
ASO Author Reflections: Undertreatment of Pancreatic Cancer After Resection: Don't Get Fooled by Favorable Final Pathology.
Ann Surg Oncol. 2021 Mar;28(3):1593-1594. doi: 10.1245/s10434-020-09079-0. Epub 2020 Aug 28.
3
ASO Author Reflections: Proposal of Tumor Size as an Index for Biologic Factor of Resectability Status of Pancreatic Ductal Adenocarcinoma.
Ann Surg Oncol. 2023 Dec;30(13):8644-8645. doi: 10.1245/s10434-023-14261-1. Epub 2023 Sep 10.
4
ASO Author Reflections: Size Matters in Distal Pancreatic Cancer: Predictor for Failure of Upfront Resection for Radiologically Resectable Disease.
Ann Surg Oncol. 2022 Dec;29(Suppl 3):568-569. doi: 10.1245/s10434-021-10686-8. Epub 2021 Aug 25.
5
ASO Author Reflections: Clinical Implications of Circulating Tumor DNA in Pancreatic Cancer Patients.ASO作者反思：循环肿瘤DNA在胰腺癌患者中的临床意义
Ann Surg Oncol. 2021 Jun;28(6):3145-3146. doi: 10.1245/s10434-020-09317-5. Epub 2021 Jan 3.
6
ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery.ASO作者反思：荧光引导手术辅助胰腺癌手术
Ann Surg Oncol. 2018 Dec;25(Suppl 3):820-821. doi: 10.1245/s10434-018-6904-9. Epub 2018 Oct 12.
7
ASO Author Reflections: Predicting Pancreatic Cancer Liver Metastasis by Integrating Primary Tumor Clinicopathologic Features and Liver Radiomics.ASO作者反思：通过整合原发性肿瘤临床病理特征和肝脏放射组学预测胰腺癌肝转移
Ann Surg Oncol. 2022 Aug;29(8):4975-4976. doi: 10.1245/s10434-022-11653-7. Epub 2022 Apr 5.
8
ASO Author Reflections: Optimal Region of Lymph Node Dissection in Distal Pancreatectomy for Pancreatic Cancer Based on Tumor Location: Should We Dissect Non-Peripancreatic Lymph Nodes for all Left-Sided Pancreatic Cancer Patients?ASO作者反思：基于肿瘤位置的胰腺癌胰体尾切除术淋巴结清扫的最佳区域：对于所有左侧胰腺癌患者，我们都应该清扫胰周外淋巴结吗？
Ann Surg Oncol. 2022 Apr;29(4):2425-2426. doi: 10.1245/s10434-021-11115-6. Epub 2022 Jan 7.
9
ASO Author Reflections: Using a CA19-9 Tumor Marker Gene Test to Assess Outcome after Pancreatic Cancer Surgery.ASO作者反思：使用CA19-9肿瘤标志物基因检测评估胰腺癌手术后的预后。
Ann Surg Oncol. 2024 May;31(5):2961-2962. doi: 10.1245/s10434-024-14974-x. Epub 2024 Jan 27.
10
ASO Author Reflections: Health Disparities in Pancreatic Cancer.美国骨科学会作者反思：胰腺癌中的健康差异
Ann Surg Oncol. 2018 Dec;25(Suppl 3):824-825. doi: 10.1245/s10434-018-6961-0. Epub 2018 Oct 30.

本文引用的文献

1
ASO Author Reflections: Enhancing Safety in Minimally Invasive Left Pancreatectomy with Polyglycolic Acid Mesh Wrapping.ASO作者反思：使用聚乙醇酸网片包裹术提高微创左胰切除术的安全性。
Ann Surg Oncol. 2025 Jul;32(7):5124-5125. doi: 10.1245/s10434-025-17263-3. Epub 2025 Apr 3.
2
Dissecting Tumor Size Underestimation in Pancreatic Cancer: A Comparative Analysis of Preoperative Treatments.剖析胰腺癌中肿瘤大小低估现象：术前治疗的比较分析
Ann Surg Oncol. 2025 May;32(5):3593-3602. doi: 10.1245/s10434-025-16917-6. Epub 2025 Jan 27.
3
Impact of Preoperative Tumor Size on Prognosis of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinomas.
术前肿瘤大小对可切除和交界可切除胰腺导管腺癌预后的影响。
Ann Surg Oncol. 2023 Dec;30(13):8621-8630. doi: 10.1245/s10434-023-14219-3. Epub 2023 Sep 1.
4
Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens.胰腺腺癌：在计算机断层扫描、磁共振成像和病理标本中测量肿瘤大小的差异。
Abdom Radiol (NY). 2020 Mar;45(3):782-788. doi: 10.1007/s00261-019-02125-w.
5
Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2-≤4, pT3: >4 cm) is More Valid and Clinically Relevant.在大多数接受切除的病例中，胰腺导管腺癌已扩散至胰腺周围软组织，这使得美国癌症联合委员会（AJCC）的T分期方案（第7版）不再适用且意义不大：基于大小的分期系统（pT1：≤2cm，pT2：>2cm-≤4cm，pT3：>4cm）更有效且与临床相关。
Ann Surg Oncol. 2016 Jun;23(6):2010-8. doi: 10.1245/s10434-016-5093-7. Epub 2016 Jan 29.
6
Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning.CT 扫描上的胰腺癌肿瘤大小与病理标本：对放射治疗计划的影响。
Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1383-90. doi: 10.1016/j.ijrobp.2010.04.058. Epub 2010 Aug 12.